Gibbs Wealth Management Haleon PLC Transaction History

Gibbs Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$9.27 - $11.41 $100,598 - $123,821	10,852 New	10,852 $113 Million
Q4 2024 Nov 04, 2025	SELL	$9.23 - $10.71 $748,654 - $868,698	-81,111 Closed	0 $0
Q3 2024 Nov 04, 2025	BUY	$8.32 - $10.7 $525,690 - $676,068	63,184 Added 352.45%	81,111 $858 Million
Q2 2024 Nov 04, 2025	BUY	$8.01 - $8.64 $35,596 - $38,396	4,444 Added 32.96%	17,927 $148 Million
Q1 2024 Nov 04, 2025	BUY	$8.02 - $8.67 $108,133 - $116,897	13,483 New	13,483 $114 Million

682

451M

114K

25.7K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.3B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Gibbs Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Gibbs Wealth Management with notifications on news.